Latest data from the Hong Kong Stock Exchange shows that on December 8, Fullgoal Fund purchased an additional 2.7925 million shares of MEDLIVE (02192) at HK$9.6336 per share, totaling approximately HK$26.9018 million. Following this acquisition, Fullgoal Fund's total holdings in MEDLIVE reached 39.352 million shares, representing a 5.36% stake.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.